|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
IUPAC Name ![]() |
(5S)-5-[[4-(5-chloropyridin-2-yl)oxypiperidin-1-yl]sulfonylmethyl]-5-methylimidazolidine-2,4-dione |
Synonyms ![]() |
AZD 1236 | AZD-1236 |
Comments |
AZD1236 is a selective MMP-9 and MMP-12 inhibitor (IC50 4.5 and 6.1nM) from Astrazeneca that, since it failed biomarker endpoints for COPD is included in the AZ Open Innovation 2014 set for repurposing. Pending any published link the structure identification is tenatative but seems likely to be the structure crystalised in WO2007106022. |
Database Links ![]() |
|
GtoPdb PubChem SID | 223366174 |
PubChem CID | 24751752 |
Search Google for chemical match using the InChIKey | SFJFBTPHDHUUPU-OAHLLOKOSA-N |
Search Google for chemicals with the same backbone | SFJFBTPHDHUUPU |
Search UniChem for chemical match using the InChIKey | SFJFBTPHDHUUPU-OAHLLOKOSA-N |
Search UniChem for chemicals with the same backbone | SFJFBTPHDHUUPU |